The US Department of Health and Human Services has reinstated the Task Force on Safer Childhood Vaccines, a panel created by ...

Costco (Nasdaq: COST) has confirmed it will not sell the abortion pill mifepristone, which is sold under the Mifeprex brand, ...

The Swiss government has met with senior executives from Roche (ROG: SIX) and Novartis (NOVN: VX) to discuss the outlook for ...

The US Food and Drug Administration (FDA) has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults ...

Flagship Pioneering has appointed Ajit Singh as chief executive (CEO)-partner of Flagship and the new CEO of Harbinger Health ...

With help from artificial intelligence, Massachusetts Institute of Technology (MIT) researchers have designed novel ...

Swiss drug developer Basilea Pharmaceutica has entered into an exclusive license agreement with Venatorx Pharmaceuticals, to ...

Schrödinger (Nasdaq: SDGR) has halted the clinical development of its oral drug SGR-2921 following the occurrence of two ...

A first-of-its-kind study from UK pharm major AstraZeneca and Macmillan Cancer Support into the barriers around access to the ...

Eli Lilly (NYSE: LLY) has entered into a collaboration with Boston-based Superluminal Medicines to develop small-molecule ...

US President Donald Trump issued an executive order on August 13 2025 instructing the Department of Health and Human Services ...

US pharma major Eli Lilly is raising the list price for its obesity drug Mounjaro (tirzepatide) in the UK by as much as 170%, as the pharma industry comes under pressure from US President Donald Trump ...